Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04662567 · ClinicalTrials.gov registry record · NA
Oral Versus Intravenous Acetaminophen for Postoperative Pain Control
A NA study, sponsored by Northwell Health.
- Terminated
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT04662567: Clinical Trial NA study, sponsored by Northwell Health.
NCT04662567 is a NA study that was terminated before completion, run by Northwell Health. The registered enrollment target is 42 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04662567, a NA study, was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The investigators are going to study the difference in postoperative pain control after administration of oral versus intravenous formulation of acetaminophen
Primary Outcome
To compare the efficacy of oral versus IV formulation of acetaminophen for controlling perioperative pain after oocyte retrieval procedure. To assess the pain level, Visual Analog Scale(VAS) score will be utilize with the minimum number 0 representing no pain and maximum number of 10 representing the highest imaginable pain level.
Interventions
- DRUG acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2021-03-12 |
| Est. Completion | 2021-09-05 |
| Phase | NA |
Why NCT04662567 stopped before completion
NCT04662567 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which acetaminophen is the first listed.
NCT04662567 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04662567 about?
NCT04662567 is a clinical study titled "Oral Versus Intravenous Acetaminophen for Postoperative Pain Control". The investigators are going to study the difference in postoperative pain control after administration of oral versus intravenous formulation of acetaminophen
What is the current status of trial NCT04662567?
This trial is currently terminated. It is a NA study. The enrollment target is 42 participants. The study started on 2021-03-12. Estimated completion is 2021-09-05.
What interventions are being tested in trial NCT04662567?
The interventions under investigation include: acetaminophen (DRUG).
Who is sponsoring clinical trial NCT04662567?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04662567's enrollment target sits among peer trials
42 1436th of 2000 higher than 555 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI